This is a competing renewal of a postdoctoral training program entitled """"""""Training in Investigative Infectious Diseases"""""""". The program is based in the Section of Infectious Diseases within the Department of Medicine at the Yale University School of Medicine. The program's overall goal is to produce exceptional physician-scientists and investigators who use modern laboratory research methods to study human infectious diseases. We expect to develop the next generation of infectious disease faculty at major universities that have the training and knowledge to span the gap between basic biology and issues in clinical infectious diseases. The program is designed primarily for M.D.'s and M.D./Ph.D.'s who have completed their subspecialty clinical training in the Infectious Diseases fellowship program at Yale, but selected M.D.s or M.D./Ph.D.s with clinical training in other fields will also be eligible to participate. The training faculty consists of 20 laboratory-based, and 9 translational researchers from 2 clinical (Medicine and Pediatrics) and 3 basic sciences departments (Microbial Pathogenesis, Immunobiology, and Microbial Diseases within the Department of Epidemiology and Public Health). The 3 major areas of research are (1) Innate Immunity and Microbes, (2) Vector-borne Diseases and (3) Molecular and Human Infectious Disease Pathogenesis. A primary mentor and co-mentor will supervise each trainee, and a training committee will monitor their progress. The trainees will have access to the newest programs and facilities at Yale, including working in the Anlyan Center for Medical Research and Education, The Boyer Center for Molecular Medicine, and/or participating in the Investigative Medicine Ph.D. program or Robert Wood Johnson Clinical Scholars program -- two novel programs designed specifically for M.D.s who have completed their clinical training. We are highly confident that this training program will provide its trainees with outstanding opportunities to pursue careers in investigative infectious diseases and bring a greater understanding of basic biological principles to current problems in medicine. This program will help train the next generation of infectious disease investigators at academic medical centers, with a focus on applying basic research to clinical medicine.

Public Health Relevance

The understanding and treatment of infectious diseases requires a cadre of highly trained physician scientists. The goals of this program are to train and develop the next generation of infectious disease investigators, by seeking highly qualified trainees, and gearing access to other highly qualified trainees and outstanding mentors, with a wide range of backgrounds. This approach has been highly successful in producing investigators devoted to dissecting the mechanisms of infectious diseases, and towards developing new prevention and therapeutic strategies for infectious diseases and national importance. This broad type of study and training is becoming even more critical as medical centers expand and evolve in the global community. It is anticipated that it will remain so with the training plan and mentorship that is provided by this program.

National Institute of Health (NIH)
National Institute of Allergy and Infectious Diseases (NIAID)
Institutional National Research Service Award (T32)
Project #
Application #
Study Section
Microbiology and Infectious Diseases B Subcommittee (MID)
Program Officer
Mcsweegan, Edward
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
Yale University
Internal Medicine/Medicine
Schools of Medicine
New Haven
United States
Zip Code
Jacobson, Karen B; Niccolai, Linda; Mtungwa, Nonhle et al. (2017) ""It's about my life"": facilitators of and barriers to isoniazid preventive therapy completion among people living with HIV in rural South Africa. AIDS Care 29:936-942
Thaden, Joshua T; Park, Lawrence P; Maskarinec, Stacey A et al. (2017) Results from a 13-Year Prospective Cohort Study Show Increased Mortality Associated with Bloodstream Infections Caused by Pseudomonas aeruginosa Compared to Other Bacteria. Antimicrob Agents Chemother 61:
Datta, Rupak; Juthani-Mehta, Manisha (2017) Burden and Management of Multidrug-Resistant Organisms in Palliative Care. Palliat Care 10:1178224217749233
Gonzalez, Daniel; Bradley, John S; Blumer, Jeffrey et al. (2017) Dalbavancin Pharmacokinetics and Safety in Children 3 Months to 11 Years of Age. Pediatr Infect Dis J 36:645-653
Strassle, Paula D; Williams, Felicia N; Napravnik, Sonia et al. (2017) Improved Survival of Patients With Extensive Burns: Trends in Patient Characteristics and Mortality Among Burn Patients in a Tertiary Care Burn Facility, 2004-2013. J Burn Care Res 38:187-193
Zielinski, Mark R; Gerashchenko, Dmitry; Karpova, Svetlana A et al. (2017) The NLRP3 inflammasome modulates sleep and NREM sleep delta power induced by spontaneous wakefulness, sleep deprivation and lipopolysaccharide. Brain Behav Immun 62:137-150
Springer, Sandra A; Di Paola, Angela; Azar, Marwan M et al. (2017) Extended-release naltrexone reduces alcohol consumption among released prisoners with HIV disease as they transition to the community. Drug Alcohol Depend 174:158-170
Doi, Yohei; Bonomo, Robert A; Hooper, David C et al. (2017) Gram-Negative Bacterial Infections: Research Priorities, Accomplishments, and Future Directions of the Antibacterial Resistance Leadership Group. Clin Infect Dis 64:S30-S35
Lindquist, Lee A; Miller, Rachel K; Saltsman, Wayne S et al. (2017) SGIM-AMDA-AGS Consensus Best Practice Recommendations for Transitioning Patients' Healthcare from Skilled Nursing Facilities to the Community. J Gen Intern Med 32:199-203
Rojas, Laura J; Salim, Madiha; Cober, Eric et al. (2017) Colistin Resistance in Carbapenem-Resistant Klebsiella pneumoniae: Laboratory Detection and Impact on Mortality. Clin Infect Dis 64:711-718

Showing the most recent 10 out of 58 publications